Trinity Point Wealth, LLC Biogen Inc. Transaction History

Trinity Point Wealth, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $670,120 - $873,910	-2,368 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $93,758 - $150,125	-362 Reduced 13.26%	2,368 $820,000
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $67,540 - $79,127	278 Added 11.34%	2,730 $764,000
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $42,999 - $64,724	-182 Reduced 6.91%	2,452 $666,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $18,269 - $21,093	69 Added 2.69%	2,634 $747,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $24,572 - $32,542	-95 Reduced 3.57%	2,565 $686,000
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $18,550 - $23,531	69 Added 2.66%	2,660 $841,000
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $165,925 - $229,268	-754 Reduced 22.54%	2,591 $769,000
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $727,336 - $815,778	3,345 New	3,345 $982,000
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $796,680 - $878,168	-3,633 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $134,576 - $210,494	621 Added 20.62%	3,633 $859,000
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $838,842 - $1.06 Million	3,012 New	3,012 $906,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Trinity Point Wealth, LLC with notifications on news.